1,101 posts by 291 firms and lawyers
Cannabis law explained by the lawyers who practise it: analysis and commentary from law firms around the world, with the Cannabis Law Journal.
Posted in Federal Agencies, Federal Law Developments, Medical Marijuana, Regulations/Compliance
In the iconic halftime scene of Friday Night Lights, Coach Gary Gaines (played with a charming ferocity the way only Billy Bob Thornton could muster) looks his team in the eyes and tells them they have exactly “two more quarters…
Every good legal thriller needs a twist, and this one’s a doozy: The DEA — the agency that’s spent over 50 years playing prohibition’s final boss — is now the one arguing marijuana doesn’t belong in Schedule I anymore, while the…
The hearing on the Notice of Proposed Rulemaking for the rescheduling of “marijuana” commenced on June 29, 2026 and will end tomorrow, July 15th. The Government brought two witnesses to the stand on the first day, and then seven…
After years of delays and political wrangling, the federal government’s long-awaited hearing on whether to move marijuana from Schedule I to Schedule III of the Controlled Substances Act is finally underway. On Jun. 29th, the DEA…
The Drug Enforcement Administration is scheduled to hold a historic hearing beginning Monday, June 29, 2026, which could extend Schedule III cannabis rescheduling to adult-use marijuana and reshape the federal regulatory…
On June 29, 2026, the Trump administration’s marijuana rescheduling effort enters a new phase as an administrative hearing, first announced on April 23, 2026, begins before a Drug Enforcement Administration (“DEA”) administrative…
On April 28, 2026, Acting Attorney General Blanche (“AG”) issued a notice of hearing concerning the proposed rule to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”).
Dr. Marty Makary resigned as FDA commissioner last week, barely a year after his Senate confirmation. HHS Secretary Robert F. Kennedy Jr. confirmed the departure and indicated the agency is searching for a replacement.
On April 23, 2026, the Department of Justice and the Drug Enforcement Administration issued an order placing FDA-approved marijuana products and marijuana products subject to a qualifying state-issued medical license in Schedule…
November 12, 2026 is not an abstraction. S. National Cannabinoid Report. It will also recriminalize products that millions of Americans use daily for sleep, anxiety, and relaxation — products that are, by any rational measure,…
The week of April 18 through April 23, 2026 produced two distinct and legally consequential federal actions on controlled substances. On April 18, President Trump signed Executive Order 14401, directing the federal government to…
S. S. Food and Drug Administration (FDA)-approved products containing marijuana and marijuana products regulated by a state medical marijuana license in Schedule III of the Controlled Substances Act (CSA).
S. Department of Justice (“DOJ”) and the Drug Enforcement Administration (“DEA”) issued an April 23, 2026 Final Order (the “Order”) proposing to immediately reclassify qualified medical marijuana products under Schedule III of…
On April 22, 2026, a final order issued by the acting U.S. attorney general and the Drug Enforcement Administration took effect, fundamentally altering the federal regulatory landscape for marijuana. The order moves FDA-approved…
Schedule I → Schedule III: A Landmark Policy Shift with Important Limits
The U.S. has joined much of the world in acknowledging medical marijuana. Let international trading begin!
” The general thrust is FDA’s assurance that it won’t interfere with a new federal initiative, which covers up to $500 of hemp-derived products for eligible Medicare patients.
As the frozen precipitation is continuing to thaw across the upper part of Mississippi, the Mississippi legislature continues to forge ahead in this year’s legislative session.
Federal cannabis rescheduling has been widely discussed as a tax, banking, and criminal-law inflection point. Far less attention has been paid to what may ultimately be its most consequential effect: a re-centering of federal…